Renaissance Capital logo

Ocean Biomedical (Aesther Healthcare Acquisition) Priced, Nasdaq: OCEA

Blank check company led by TRxADE Health executives targeting the pharma and medical device sectors (completed 2/15/2023).

Industry: SPAC

Latest Trade: $0.89 0.00 (0.0%)

First Day Return: +0.6%

Return from IPO: -91.1%

Industry: SPAC

We are a newly-organized blank check company. While we may pursue an initial business combination opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business and it is our current intention to pursue prospective targets that are focused in the pharmaceutical and medical devices sectors. We anticipate focusing our investment effort broadly across the Pharmaceutical and medical devices sectors. We believe that our investment and operating expertise across multiple industry verticals will give us a large, addressable universe of potential targets. The diversity of the target universe and the number of largely uncorrelated subsectors maximizes that likelihood that our management team will be able to identify and execute an attractive transaction. At the time of preparing this prospectus, we have not identified any specific business combination, nor has anyone on our behalf initiated or engaged in any substantive discussions, formal or otherwise, related to such a transaction. Our efforts to date are limited to organizational activities related to this offering.
more less
IPO Data
IPO File Date 07/19/2021
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 10.0
Deal Size ($mm) $100
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 09/14/2021
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 10.0
Deal Size ($mm) $100
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
EF Hutton
Company Data
Headquarters New York, NY, United States
Founded 2021
Employees at IPO 2

Ocean Biomedical (Aesther Healthcare Acquisition) (OCEA) Performance